INOVIO PHARMACEUTICALS, INC. - INO

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
Feb 17, 2026 SCHEDULE 13G/A Alyeska Investment Group, L.P. 5.99% 4,000,000 View
Feb 17, 2026 SCHEDULE 13G/A Alyeska Fund GP, LLC 5.99% 4,000,000 View
Feb 17, 2026 SCHEDULE 13G/A Anand Parekh 5.99% 4,000,000 View
Jan 30, 2026 SCHEDULE 13G/A The Vanguard Group 4.96% 3,315,579 View
Dec 08, 2025 SCHEDULE 13G/A JANUS HENDERSON GROUP PLC 9.99% 6,666,295 View
Dec 05, 2025 SCHEDULE 13G FMR LLC 14.8% 9,846,664 View
Dec 05, 2025 SCHEDULE 13G Abigail P. Johnson 14.8% 9,846,664 View
Nov 14, 2025 SCHEDULE 13G Alyeska Investment Group, L.P. 7.53% 4,000,000 View
Nov 14, 2025 SCHEDULE 13G Alyeska Fund GP, LLC 7.53% 4,000,000 View
Nov 14, 2025 SCHEDULE 13G Anand Parekh 7.53% 4,000,000 View
Nov 14, 2025 SCHEDULE 13G JANUS HENDERSON GROUP PLC 6.2% 3,266,260 View
Nov 14, 2025 SCHEDULE 13G Janus Henderson Biotech Innovation Master Fund Ltd 5.3% 2,802,530 View
Nov 14, 2025 SCHEDULE 13G/A Deep Track Capital, LP 2.41% 1,314,796 View
Nov 14, 2025 SCHEDULE 13G/A Deep Track Biotechnology Master Fund, Ltd. 2.41% 1,314,796 View
Nov 14, 2025 SCHEDULE 13G/A David Kroin 2.41% 1,314,796 View
Nov 13, 2025 SCHEDULE 13G Adage Capital Management, L.P. 9.99% 5,517,650 View
Nov 13, 2025 SCHEDULE 13G Robert Atchinson 9.99% 5,517,650 View
Nov 13, 2025 SCHEDULE 13G Phillip Gross 9.99% 5,517,650 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.